« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 3
, Pages 790-792
, March 2010
Treatment of heparin-induced thrombocytopenia after cardiac surgery: Preliminary experience with fondaparinux
References
- . Fondaparinux as a treatment option for heparin-induced thrombocytopenia. Pharmacotherapy. 2007;27:921–926
- . Heparin-induced thrombocytopenia: recognition, treatment and prevention: the Seventh ACCP Conference on Antithrombotic and thrombolytic therapy. Chest. 2005;127:416
- . Factor Xa or thrombin: is factor Xa a better target?. J Thromb Haemost. 2007;5(Suppl 1):60–64
- . Anticoagulant use in patients with chronic renal failure. Am J Cardiovasc Drugs. 2005;5:291–305
- Oasis 5 Investigators. Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST segment elevation acute coronary syndromes. Ann Intern Med. 2007;147:304–310
Disclosures: None.
PII: S0022-5223(08)02045-X
doi: 10.1016/j.jtcvs.2008.11.032
© 2010 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 3
, Pages 790-792
, March 2010
